SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES AND EXCHANGE ACT OF 1934
November 12, 2004
(November 5, 2004)
Date of Report (Date of earliest event reported)
SPECTRUM PHARMACEUTICALS, INC.
| Delaware | 000-28782 | 93-0979187 | ||
| (State or other Jurisdiction of Incorporation) |
(Commission File Number) | (IRS Employer Identification Number) |
| 157 Technology Drive | ||
| Irvine, California | 92618 | |
| (Address of principal executive offices) | (Zip Code) |
(949) 788-6700
(Registrant’s telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
| Item 3.02 Unregistered Sales of Equity Securities | ||||||||
| SIGNATURES | ||||||||
Item 3.02 Unregistered Sales of Equity Securities
On November 5, 2004, we issued 190,000 shares of our common stock upon conversion of 95 shares of our Series E Preferred Stock, at a conversion price of $5.00 per share. The shares of our common stock were issued without registration under the Securities Act of 1933 in reliance upon the exemption from registration provided under Section 3(a)(9) of the Securities Act.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 12, 2004 |
||||
| SPECTRUM PHARMACEUTICALS, INC. | ||||
| By: | /s/ Shyam K. Kumaria | |||
| Name: Title: |
Shyam K. Kumaria Vice President, Finance |
|||